The company's average rating is Strong Buy from 1 analysts. Do analysts base this consensus on technical analyses? We know that typical technical analysis utilizes price momentum, patterns, and trends looking at historical prices. It aims to identify signals based on Harrow Health market sentiment investors' perception of the future value of Harrow. Let us look at a few aspects of Harrow technical analysis.
Using predictive
technical analysis, we can analyze different prices and returns patterns and
diagnose historical swings to determine the real value of Harrow Health. In general, sophisticated investors focus on analyzing Harrow Health stock price patterns and their correlations with different microeconomic environment and drivers. They apply predictive analytics to build Harrow Health's daily price indicators and compare them against related drivers such as
momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional
technical analysis and
fundamental analysis, we attempt to find the most accurate representation of
Harrow Health's intrinsic value. In addition to deriving basic predictive indicators for Harrow Health, many experienced traders also check how macroeconomic factors affect Harrow Health price patterns. Please read more on our
technical analysis page or use our predictive modules below to complement your research.
Sophisticated investors, who have witnessed
many market ups and downs, anticipate that the market will even out over time. This tendency of Harrow Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Harrow Health. Your research has to be compared to or analyzed against Harrow Health's peers to derive any actionable benefits. When done correctly, Harrow Health's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Harrow Health.
How important is Harrow Health's Liquidity
Harrow Health
financial leverage refers to using borrowed capital as a funding source to finance Harrow Health ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Harrow Health financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to Harrow Health's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Harrow Health's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the
breakdown between Harrow Health's total debt and its cash.
Harrow Health Gross Profit
Harrow Health Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Harrow Health previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Harrow Health Gross Profit growth over the last 10 years. Please check Harrow Health's
gross profit and other
fundamental indicators for more details.
Closer look at Harrow Health Mean Deviation
Harrow Health has current Mean Deviation of 3.47. The mean deviation of the equity instrument is the first measure of the distances between each value of security historical prices and the mean. It gives us an idea of how spread out from the center the distribution of returns.
Mean Deviation is the average of the absolute values of the differences between price distribution numbers and their mean. Mean deviation of equity instrument with a lot of historical data is a biased estimator because the time horizon used in calculation will always be much smaller than the entire price history of the equity. The mean deviation is typically used as a measure of dispersion for small investment horizon, otherwise standard deviation is a better measure of dispersion.
Mean Deviation | = | SUM(RET DEV) N |
| = | 3.47 |
| SUM | = | Summation notation |
| RET DEV | = | Sum of return deviations of Harrow Health |
| N | = | Number of calculation points for selected time horizon |
Let's now compare Harrow Health Mean Deviation to its closest peers:
| HROW | 3.472172391184572 |
| DRRX | 3.52 |
| ENDP | 3.01 |
| EVOK | 4.29 |
| ACB | 5.38 |
Will Harrow continue to climb?
Harrow Health latest coefficient of variation rises over 799.35. Harrow Health shows above-average downside volatility for the selected time horizon. We advise investors to inspect Harrow Health further and ensure that all market timing and asset allocation strategies are consistent with the estimation of Harrow Health future alpha. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Harrow Health's stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Harrow Health's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.
Our Final Take On Harrow Health
While some other entities within the drug manufacturers—specialty & generic industry are still a little expensive, even after the recent corrections, Harrow Health may offer a potential longer-term growth to sophisticated investors. To conclude, as of the 8th of March 2021, our actual 30 days buy-hold-sell recommendation on the venture is
Strong Hold. We believe Harrow Health is
undervalued with
below average probability of distress for the next two years.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Raphi Shpitalnik is a Junior Member of Macroaxis Editorial Board. Raphael is a young entrepreneur who joined Macroaxis on a part-time basis at the beginning of the pandemic and eventually acquired a real taste for investing and fintech. He likes to analyze different equity instruments across a wide range of industries, focusing primarily on consumer products, sports, fintech, cannabis, and AI.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of Harrow Health. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com